PureTech's video game for AD­HD gets big Se­ries D fi­nanc­ing; Day One in­creas­es term sheet ahead of ex­pect­ed IPO

The mak­er of the first pre­scrip­tion video game treat­ment an­nounced it re­ceived $110 mil­lion in Se­ries D fi­nanc­ing Wednes­day.

Ak­ili’s En­deav­or­Rx is an FDA-ap­proved video …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER